Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs

Konerman MA, Mehta SH, Sutcliffe CG, Vu T, Higgins Y, Torbenson MS, et al. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology. 2014;59(3):767-775.

Publication Type:

Journal Article

Authors:

Konerman, M.A.; S H Mehta; Sutcliffe, C.G.; Vu, T.; Higgins, Y.; Torbenson, M.S.; Moore, R.D.; Thomas, D.L.; M S Sulkowski

Source:

Hepatology, Volume 59, Issue 3, p.767-775 (2014)

Keywords:

Adult, Alanine, analysis, Baltimore, Biopsy, Body Mass Index, coinfection, Disease, Disease Progression, epidemiology, Female, Fibrosis, Genotype, genotype 1, HCV, Hepatitis C,Chronic, HIV Infections, Human, Humans, Incidence, Liver, Liver Cirrhosis, Male, Medicine, Middle Aged, Multivariate Analysis, Odds Ratio, pathology, Patients, Prospective Studies, Research, Research Support, Risk, Risk Factors, Serum, Severity of Illness Index, Time, treatment, virology

Notes:

PMC3943751

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24436062

Export Citation:

RIS Format

Top